Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 3683026, 15 pages
https://doi.org/10.1155/2018/3683026
Research Article

Combination of Mitochondrial and Plasma Membrane Citrate Transporter Inhibitors Inhibits De Novo Lipogenesis Pathway and Triggers Apoptosis in Hepatocellular Carcinoma Cells

1Department of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand
2Clinical Research Unit, Faculty of Medicine, Naresuan University, Phitsanulok 65000, Thailand
3Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand
4KaLy-Cell, 20A rue du Général Leclerc, 67115 Plobsheim, France
5Laboratoire de Toxicologie Cellulaire, Université de Bourgogne Franche-Comté, EA 4267, Besançon, France
6Department of Medicine, Faculty of Medicine, Naresuan University, Phitsanulok 65000, Thailand
7Centre of Excellence in Medical Biotechnology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand
8Center of Excellence in Petroleum, Petrochemicals and Advanced Materials, Faculty of Science, Naresuan University, Phitsanulok 65000, Thailand

Correspondence should be addressed to Piyarat Srisawang; ht.ca.un@starayip

Received 14 September 2017; Revised 23 November 2017; Accepted 3 December 2017; Published 9 January 2018

Academic Editor: Senthil Kumar Venugopal

Copyright © 2018 Wan-angkan Poolsri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  2. P. Jozwiak, E. Forma, M. Bryś, and A. Krześlak, “O-GlcNAcylation and metabolic reprograming in cancer,” Frontiers in Endocrinology, vol. 5, article no. 145, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Lu, M. Tan, and Q. Cai, “The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism,” Cancer Letters, vol. 356, no. 2, pp. 156–164, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. M. G. V. Heiden, L. C. Cantley, and C. B. Thompson, “Understanding the warburg effect: the metabolic requirements of cell proliferation,” Science, vol. 324, no. 5930, pp. 1029–1033, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Y. Lunt and M. G. V. Heiden, “Aerobic glycolysis: meeting the metabolic requirements of cell proliferation,” Annual Review of Cell and Developmental Biology, vol. 27, no. 1, pp. 441–464, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Currie, A. Schulze, R. Zechner, T. C. Walther, and R. V. Farese Jr., “Cellular fatty acid metabolism and cancer,” Cell Metabolism, vol. 18, no. 2, pp. 153–161, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. L. K. Boroughs and R. J. Deberardinis, “Metabolic pathways promoting cancer cell survival and growth,” Nature Cell Biology, vol. 17, no. 4, pp. 351–359, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Zaidi, L. Lupien, N. B. Kuemmerle, W. B. Kinlaw, J. V. Swinnen, and K. Smans, “Lipogenesis and lipolysis: The pathways exploited by the cancer cells to acquire fatty acids,” Progress in Lipid Research, vol. 52, no. 4, pp. 585–589, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Zhang, F. Song, X. Zhao et al., “EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer,” Molecular Cancer, vol. 16, no. 1, 2017. View at Publisher · View at Google Scholar
  10. H. Impheng, L. Richert, D. Pekthong et al., “[6]-gingerol inhibits de novo fatty acid synthesis and carnitine palmitoyltransferase-1 activity which triggers apoptosis in HepG2,” American Journal of Cancer Research, vol. 5, no. 4, pp. 1319–1336, 2015. View at Google Scholar · View at Scopus
  11. H. Impheng, S. Pongcharoen, L. Richert, D. Pekthong, and P. Srisawang, “The selective target of capsaicin on FASN expression and de novo fatty acid synthesis mediated through ROS generation triggers apoptosis in HepG2 Cells,” PLoS ONE, vol. 9, no. 9, Article ID e107842, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Nishizawa, H. Sumi, Y. Satoh et al., “In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor,” European Journal of Pharmacology, vol. 807, pp. 21–31, 2017. View at Publisher · View at Google Scholar
  13. M.-D. Wang, H. Wu, G.-B. Fu et al., “Acetyl-coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients,” Hepatology, vol. 63, no. 4, pp. 1272–1286, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Xin, Z. Qiao, J. Li et al., “miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer,” Oncotarget , vol. 7, no. 28, pp. 44252–44265, 2016. View at Publisher · View at Google Scholar
  15. R. Singh, V. Yadav, S. Kumar, and N. Saini, “MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1,” Scientific Reports, vol. 5, Article ID 17454, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. F. E. Sluse, A. J. Meijer, and J. M. Tager, “Anion translocators in rat-heart mitochondria,” FEBS Letters, vol. 18, no. 1, pp. 149–153, 1971. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Huizing, W. Ruitenbeek, L. P. Van den Heuvel et al., “Human mitochondrial transmembrane metabolite carriers: Tissue distribution and its implication for mitochondrial disorders,” Journal of Bioenergetics and Biomembranes, vol. 30, no. 3, pp. 277–284, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Bhalla, B. J. Hwang, R. E. Dewi et al., “PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis,” Cancer Research, vol. 71, no. 21, pp. 6888–6898, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. R. S. Kaplan, H. P. Morris, and P. S. Coleman, “Kinetic Characteristics of Citrate Influx and Efflux with Mitochondria from Morris Hepatomas 3924A and 16,” Cancer Research, vol. 42, no. 11, pp. 4399–4407, 1982. View at Google Scholar · View at Scopus
  20. V. K. Kolukula, G. Sahu, A. Wellstein et al., “SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker,” Oncotarget , vol. 5, no. 5, pp. 1212–1225, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Sun, S. Aluvila, R. Kotaria, J. A. Mayor, D. E. Walters, and R. S. Kaplan, “Mitochondrial and plasma membrane citrate transporters: discovery of selective inhibitors and application to structure/function analysis,” Molecular and Cellular Pharmacology, vol. 2, no. 3, pp. 101–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Inoue, L. Zhuang, D. M. Maddox, S. B. Smith, and V. Ganapathy, “Human sodium-coupled citrate transporter, the orthologue of Drosophila Indy, as a novel target for lithium action,” Biochemical Journal, vol. 374, no. 1, pp. 21–26, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. D. M. Willmes and A. L. Birkenfeld, “The role of indy in metabolic regulation,” Computational and Structural Biotechnology Journal, vol. 6, no. 7, p. e201303020, 2013. View at Publisher · View at Google Scholar
  24. F. Schwarz, Z. Karadeniz, A. Fischer-Rosinsky, D. M. Willmes, J. Spranger, and A. L. Birkenfeld, “Knockdown of Indy/CeNac2 extends Caenorhabditis elegans life span by inducing AMPK/aak-2,” AGING, vol. 7, no. 8, pp. 553–567, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Rogina, R. A. Reenan, S. P. Nilsen, and S. L. Helfand, “Extended life-span conferred by cotransporter gene mutations in Drosophila,” Science, vol. 290, no. 5499, pp. 2137–2140, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Huard, J. Brown, J. C. Jones et al., “Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5),” Scientific Reports, vol. 5, Article ID 17391, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Brachs, A. F. Winkel, H. Tang et al., “Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice,” Molecular Metabolism, vol. 5, no. 11, pp. 1072–1082, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. E. J. Park, J. H. Lee, G.-Y. Yu et al., “Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression,” Cell, vol. 140, no. 2, pp. 197–208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Shimizu, T. Tanaka, and H. Moriwaki, “Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis,” Seminars in Immunopathology, vol. 35, no. 2, pp. 191–202, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. G. B. Leandro, J. M. Espindola-Netto, M. C. F. Vianna et al., “Exogenous citrate impairs glucose tolerance and promotes visceral adipose tissue inflammation in mice,” British Journal of Nutrition, vol. 115, no. 6, pp. 967–973, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Li, D. Li, E. Y. Choi et al., “Silencing of solute carrier family 13 member 5 disrupts energy homeostasis and inhibits proliferation of human hepatocarcinoma cells,” The Journal of Biological Chemistry, vol. 292, no. 33, pp. 13890–13901, 2017. View at Publisher · View at Google Scholar
  32. S. Kant, A. Kumar, and S. M. Singh, “Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: Role of cell survival regulatory molecules,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1820, no. 11, pp. 1764–1773, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. C. G. Yedjou, H. M. Tchounwou, and P. B. Tchounwou, “DNA damage, cell cycle arrest, and apoptosis induction caused by lead in human leukemia cells,” International Journal of Environmental Research and Public Health, vol. 13, no. 1, article no. 56, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. T. M. Puig, J. Relat, P. F. Marrero, D. Haro, J. Brunet, and R. Colomer, “Green tea catechin inhibits fatty acid synthase without stimulating carnitine palmitoyltransferase-1 or inducing weight loss in experimental animals,” Anticancer Reseach, vol. 28, no. 6 A, pp. 3671–3676, 2008. View at Google Scholar · View at Scopus
  35. P. Li, W. Tian, and X. Ma, “Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells,” Molecular Cancer, vol. 13, no. 1, article 138, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Puig, A. Vázquez-Martín, J. Relat et al., “Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75,” Breast Cancer Research and Treatment, vol. 109, no. 3, pp. 471–479, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. J. N. Thupari, M. L. Pinn, and F. P. Kuhajda, “Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity,” Biochemical and Biophysical Research Communications, vol. 285, no. 2, pp. 217–223, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Dobrzyn, A. Dobrzyn, M. Miyazaki et al., “Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 101, no. 17, pp. 6409–6414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Huang, A. L. McIntosh, G. G. Martin et al., “Inhibitors of fatty acid synthesis induce PPAR α -regulated fatty acid β -oxidative genes: Synergistic roles of L-FABP and glucose,” PPAR Research, Article ID 865604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. W. Zhou, F. H. Wan, L. E. Landree et al., “Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells,” Cancer Research, vol. 67, no. 7, pp. 2964–2971, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Wang, C. Xu, M. Sun, D. Luo, D.-F. Liao, and D. Cao, “Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis,” Biochemical and Biophysical Research Communications, vol. 385, no. 3, pp. 302–306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. A. V. Bazhin, P. P. Philippov, and S. Karakhanova, “Reactive Oxygen Species in Cancer Biology and Anticancer Therapy,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 4197815, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. Y.-H. Ling, L. Liebes, Y. Zou, and R. Perez-Soler, “Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to bortezomib, a novel proteasome inhibitor, in human H460 Non-small cell lung cancer cells,” The Journal of Biological Chemistry, vol. 278, no. 36, pp. 33714–33723, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. P.-Y. Wang, N. Neretti, R. Whitaker et al., “Long-lived Indy and calorie restriction interact to extend life span,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 106, no. 23, pp. 9262–9267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Birkenfeld, Deletion of the Mammalian INDY Homologue Mimics Aspects of Dietary Restriction and Protects Against Adiposity and Insulin Resistance in Mice, vol. 14, 2011.
  46. R. Dentin, F. Benhamed, I. Hainault et al., “Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice,” Diabetes, vol. 55, no. 8, pp. 2159–2170, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Postic and J. Girard, “Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice,” The Journal of Clinical Investigation, vol. 118, no. 3, pp. 829–838, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Jiang, A. Boufersaoui, C. Yang et al., “Quantitative metabolic flux analysis reveals an unconventional pathway of fatty acid synthesis in cancer cells deficient for the mitochondrial citrate transport protein,” Metabolic Engineering, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Inoue, L. Zhuang, and V. Ganapathy, “Human Na+-coupled citrate transporter: Primary structure, genomic organization, and transport function,” Biochemical and Biophysical Research Communications, vol. 299, no. 3, pp. 465–471, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. D. Bhutia, J. J. Kopel, J. J. Lawrence, V. Neugebauer, and V. Ganapathy, “Plasma membrane Na+-coupled citrate transporter (SLC13A5) and neonatal epileptic encephalopathy,” Molecules, vol. 22, no. 3, article no. 378, 2017. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Weerachayaphorn and A. M. Pajor, “Identification of transport pathways for citric acid cycle intermediates in the human colon carcinoma cell line, Caco-2,” Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1778, no. 4, pp. 1051–1059, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. M. E. Mycielska, C. P. Palmer, W. J. Brackenbury, and M. B. A. Djamgoz, “Expression of Na+-dependent citrate transport in a strongly metastatic human prostate cancer PC-3M cell line: Regulation by voltage-gated Na+ channel activity,” The Journal of Physiology, vol. 563, no. 2, pp. 393–408, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Li, H. Li, B. Garzel et al., “SLC13A5 Is a novel transcriptional target of the pregnane x receptor and sensitizes drug-induced steatosis in human liver,” Molecular Pharmacology, vol. 87, no. 4, pp. 674–682, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. O. Catalina-Rodriguez, V. K. Kolukula, Y. Tomita et al., “The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis,” Oncotarget , vol. 3, no. 10, pp. 1220–1235, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Zeng, G.-Z. Wu, K. J. Goh et al., “Saturated fatty acids modulate cell response to DNA damage: Implication for their role in tumorigenesis,” PLoS ONE, vol. 3, no. 6, Article ID e2329, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. Z. Li, Z. Dong, D. Myer et al., “Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers,” BMC Cancer, vol. 10, no. 1, 2010. View at Publisher · View at Google Scholar
  57. W. Tu, R. Cook-Johnson, M. James, B. Mühlhäusler, and R. Gibson, “Omega-3 long chain fatty acid synthesis is regulated more by substrate levels than gene expression,” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 83, no. 2, pp. 61–68, 2010. View at Publisher · View at Google Scholar
  58. K. Brusselmans, E. de Schrijver, G. Verhoeven, and J. V. Swinnen, “RNA interference—mediated silencing of the acetyl-Coa-carboxylase-α gene induces growth inhibition and apoptosis of prostate cancer cells,” Cancer Research, vol. 65, no. 15, pp. 6719–6725, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Migita, S. Okabe, K. Ikeda et al., “Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells,” International Journal of Cancer, vol. 135, no. 1, pp. 37–47, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. P. V. Escriba, X. Busquets, J. Inokuchi et al., “Membrane lipid therapy: modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment,” Progress in Lipid Research, vol. 59, pp. 38–53, 2015. View at Publisher · View at Google Scholar
  61. Y. Cui, P. Xing, Y. Wang et al., “NADPH accumulation is responsible for apoptosis in breast cancer cells induced by fatty acid synthase inhibition,” Oncotarget, vol. 8, pp. 32576–32585, 2017. View at Publisher · View at Google Scholar
  62. F. A. Rossato, K. G. Zecchin, P. G. La Guardia et al., “Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic Melan-A cells associated with inhibition of mitochondrial respiration,” PLoS ONE, vol. 9, no. 6, Article ID e101060, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. T. Migita, S. Okabe, K. Ikeda et al., “Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact,” The American Journal of Pathology, vol. 182, no. 5, pp. 1800–1810, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Hillar, V. Lott, and B. Lennox, “Correlation of the effects of citric acid cycle metabolites on succinate oxidation by rat liver mitochondria and submitochondrial particles,” Journal of Bioenergetics, vol. 7, no. 1, pp. 1–15, 1975. View at Publisher · View at Google Scholar · View at Scopus
  65. D. B. Zorov, M. Juhaszova, and S. J. Sollott, “Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release,” Physiological Reviews, vol. 94, no. 3, pp. 909–950, 2014. View at Publisher · View at Google Scholar
  66. A. Lemarie, L. Huc, E. Pazarentzos, A.-L. Mahul-Mellier, and S. Grimm, “Specific disintegration of complex II succinate:Ubiquinone oxidoreductase links pH changes to oxidative stress for apoptosis induction,” Cell Death & Differentiation, vol. 18, no. 2, pp. 338–349, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. N. Kang, J. Zhang, F. Qiu, S. Tashiro, S. Onodera, and T. Ikejima, “Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways,” Cancer Letters, vol. 294, no. 2, pp. 147–158, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Zhu, Y. Yang, S. Liu et al., “Anticancer effect of thalidomide in vitro on human osteosarcoma cells,” Oncology Reports, vol. 36, no. 6, pp. 3545–3551, 2016. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Pant, A. K. Yadav, P. Gupta, R. Islam, A. Saraya, and S. K. Venugopal, “Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells,” Redox Biology, vol. 12, pp. 340–349, 2017. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. A. Hannun and L. M. Obeid, “Principles of bioactive lipid signalling: lessons from sphingolipids,” Nature Reviews Molecular Cell Biology, vol. 9, no. 2, pp. 139–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. B. Oskouian and J. D. Saba, “Cancer treatment strategies targeting sphingolipid metabolism,” Advances in Experimental Medicine and Biology, vol. 688, pp. 185–205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Bektas, P. S. Jolly, C. Müller, J. Eberle, S. Spiegel, and C. C. Geilen, “Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: Role of Bcl-2 expression,” Oncogene, vol. 24, no. 1, pp. 178–187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Sawada, S. Nakashima, Y. Banno et al., “Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells,” Oncogene, vol. 19, no. 31, pp. 3508–3520, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. L. J. Beverly, L. A. Howell, M. Hernandez-Corbacho, L. Casson, J. E. Chipuk, and L. J. Siskind, “BAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins,” Biochemical Journal, vol. 452, no. 1, pp. 111–119, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. M. A. Aon, N. Bhatt, and S. Cortassa, “Mitochondrial and cellular mechanisms for managing lipid excess,” Frontiers in Physiology, vol. 5, Article ID 00282, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Roden, “Muscle triglycerides and mitochondrial function: Possible mechanisms for the development of type 2 diabetes,” International Journal of Obesity, vol. 29, pp. S111–S115, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Bandyopadhyay, R. Zhan, Y. Wang et al., “Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells,” Cancer Research, vol. 66, no. 11, pp. 5934–5940, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. H. Shao, E. M. Mohamed, G. G. Xu et al., “Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer,” Oncotarget , vol. 7, no. 4, pp. 3832–3846, 2016. View at Publisher · View at Google Scholar · View at Scopus